Filing Flows › Integer Holdings (ITGR) › Q2 2026 › vs Q2 2025
Integer Holdings (ITGR) Q2 2026 vs Q2 2025 (year over year)
Integer Holdings's revenue fell $12.4M (-3%) from $476M in Q2 2025 to $464M in Q2 2026. The biggest changes: Other Markets −$7.6M (-43%); Cardio & Vascular −$6.5M (-2%); Cardiac Rhythm Management & Neuromodulation +$1.7M (+1%). Gross margin 24.3% against 27.1% (-2.8 pts).
Integer Holdings, Q2 2026: revenue $464M (-3% year over year), operating margin 7.4%, net earnings $23.6M, operating cash flow $59.7M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 24.3% | 27.1% | -2.8 pts |
| Operating margin | 7.4% | 12.5% | -5.0 pts |
| Net margin | 5.1% | 7.8% | -2.7 pts |
| Free cash flow margin | 8.0% | 5.2% | +2.8 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Cardio & Vascular | $280M | $287M | −$6.5M | -2% |
| Cardiac Rhythm Management & Neuromodulation | $174M | $172M | $1.7M | +1% |
| Other Markets | $10.1M | $17.6M | −$7.6M | -43% |
| Revenue | $464M | $476M | −$12.4M | -3% |
| Gross profit | $113M | $129M | −$16.2M | -13% |
| Cost of revenue | $351M | $347M | $3.8M | +1% |
| Operating profit | $34.5M | $59.3M | −$24.8M | -42% |
| Operating expenses | $78.4M | $69.8M | $8.6M | +12% |
| Pre-tax earnings | $23.3M | $45.6M | −$22.3M | -49% |
| Other expense, net | $11.2M | $13.7M | −$2.5M | -18% |
| Research & development | $11.3M | $14.2M | −$3.0M | -21% |
| SG&A | $57.7M | $52.9M | $4.8M | +9% |
| Other operating costs | $9.4M | $2.7M | $6.8M | +256% |
| Income tax benefit | $314K | −$8.6M | $8.9M | — |
| Net earnings | $23.6M | $37.0M | −$13.4M | -36% |
| Depreciation & amortization | $34.5M | $32.3M | $2.3M | +7% |
| Share-based compensation | $5.4M | $5.7M | −$273K | -5% |
| Working capital & other | $3.8M | $31.1M | −$27.3M | -88% |
| Operating cash flow | $59.7M | $43.9M | $15.9M | +36% |
| Free cash flow (OCF − capex) | $37.0M | $24.9M | $12.2M | +49% |
| Capital expenditures | $22.7M | $19.0M | $3.7M | +19% |
Questions
How much did Integer Holdings's revenue grow year over year in Q2 2026?
Integer Holdings's revenue fell $12.4M (-3%) from $476M in Q2 2025 to $464M in Q2 2026.
What drove Integer Holdings's revenue change in Q2 2026?
Other Markets −$7.6M (-43%); Cardio & Vascular −$6.5M (-2%); Cardiac Rhythm Management & Neuromodulation +$1.7M (+1%).